Logo image of EVLO

EVELO BIOSCIENCES INC (EVLO) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:EVLO - US2997342025 - Common Stock

0.3165 USD
-0.05 (-14.46%)
Last: 12/11/2023, 8:00:02 PM
0.3159 USD
0 (-0.19%)
After Hours: 12/11/2023, 8:00:02 PM
Fundamental Rating

0

Taking everything into account, EVLO scores 0 out of 10 in our fundamental rating. EVLO was compared to 525 industry peers in the Biotechnology industry. EVLO may be in some trouble as it scores bad on both profitability and health. EVLO has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • EVLO had negative earnings in the past year.
  • In the past year EVLO has reported a negative cash flow from operations.
EVLO Yearly Net Income VS EBIT VS OCF VS FCFEVLO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 -20M -40M -60M -80M -100M

1.2 Ratios

  • EVLO's Return On Assets of -399.71% is on the low side compared to the rest of the industry. EVLO is outperformed by 97.84% of its industry peers.
Industry RankSector Rank
ROA -399.71%
ROE N/A
ROIC N/A
ROA(3y)-140.08%
ROA(5y)-110.47%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EVLO Yearly ROA, ROE, ROICEVLO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 1K -1K 2K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for EVLO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EVLO Yearly Profit, Operating, Gross MarginsEVLO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022

More info and screens

0

2. Health

2.1 Basic Checks

  • The number of shares outstanding for EVLO has been increased compared to 1 year ago.
  • EVLO has a worse debt/assets ratio than last year.
EVLO Yearly Shares OutstandingEVLO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 1M 2M 3M 4M 5M
EVLO Yearly Total Debt VS Total AssetsEVLO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M

2.2 Solvency

  • EVLO has an Altman-Z score of -53.01. This is a bad value and indicates that EVLO is not financially healthy and even has some risk of bankruptcy.
  • EVLO has a worse Altman-Z score (-53.01) than 97.01% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -53.01
ROIC/WACCN/A
WACCN/A
EVLO Yearly LT Debt VS Equity VS FCFEVLO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 50M -50M 100M -100M

2.3 Liquidity

  • A Current Ratio of 0.47 indicates that EVLO may have some problems paying its short term obligations.
  • With a Current ratio value of 0.47, EVLO is not doing good in the industry: 95.02% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.47 indicates that EVLO may have some problems paying its short term obligations.
  • EVLO's Quick ratio of 0.47 is on the low side compared to the rest of the industry. EVLO is outperformed by 94.52% of its industry peers.
Industry RankSector Rank
Current Ratio 0.47
Quick Ratio 0.47
EVLO Yearly Current Assets VS Current LiabilitesEVLO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M

More info and screens

1

3. Growth

3.1 Past

  • EVLO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -131.81%.
EPS 1Y (TTM)-131.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%87.46%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 14.98% on average over the next years. This is quite good.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y85.07%
EPS Next 2Y38.62%
EPS Next 3Y24.47%
EPS Next 5Y14.98%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EVLO Yearly Revenue VS EstimatesEVLO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 2030 20M 40M 60M 80M 100M
EVLO Yearly EPS VS EstimatesEVLO Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -10 -20 -30 -40 -50

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

  • EVLO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for EVLO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EVLO Price Earnings VS Forward Price EarningsEVLO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EVLO Per share dataEVLO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -5 -10 -15 -20 -25

4.3 Compensation for Growth

  • A more expensive valuation may be justified as EVLO's earnings are expected to grow with 24.47% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.62%
EPS Next 3Y24.47%

More info and screens

0

5. Dividend

5.1 Amount

  • EVLO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EVELO BIOSCIENCES INC / EVLO FAQ

What is the fundamental rating for EVLO stock?

ChartMill assigns a fundamental rating of 0 / 10 to EVLO.


What is the valuation status of EVELO BIOSCIENCES INC (EVLO) stock?

ChartMill assigns a valuation rating of 1 / 10 to EVELO BIOSCIENCES INC (EVLO). This can be considered as Overvalued.


Can you provide the profitability details for EVELO BIOSCIENCES INC?

EVELO BIOSCIENCES INC (EVLO) has a profitability rating of 0 / 10.